BIOCONJUGATE CHEMISTRY
Scope & Guideline
Catalyzing Progress in Biomedical Innovation
Introduction
Aims and Scopes
- Bioconjugation Techniques:
The journal explores various methods of bioconjugation, including chemoselective reactions, click chemistry, and enzyme-mediated coupling, aimed at creating stable and functional bioconjugates. - Therapeutic Applications:
Research published in the journal often highlights the development of bioconjugates for targeted drug delivery, antibody-drug conjugates (ADCs), and vaccine formulations, demonstrating their potential in improving therapeutic efficacy. - Molecular Imaging and Diagnostics:
The journal emphasizes the integration of bioconjugates with imaging agents for enhanced diagnostic capabilities, including PET and fluorescence imaging, showcasing the role of bioconjugates in precision medicine. - Nanotechnology in Bioconjugation:
There is a significant focus on the use of nanocarriers and nanomaterials in bioconjugation, aiming to improve the pharmacokinetics and biodistribution of therapeutic agents. - Research on Biomolecular Interactions:
Studies on the interactions between bioconjugates and biological systems are prevalent, contributing to a deeper understanding of how modifications affect biological activity and stability.
Trending and Emerging
- Targeted Drug Delivery Systems:
There is a significant rise in research focused on targeted drug delivery systems, particularly those utilizing antibody-drug conjugates (ADCs) and other specific targeting mechanisms to enhance therapeutic efficacy. - Nanoparticle-based Bioconjugates:
The use of nanoparticles in bioconjugation is increasingly popular, with studies exploring their roles in drug delivery, imaging, and as carriers for therapeutic agents, indicating a shift towards nanotechnology in bioconjugate applications. - Bioorthogonal Chemistry:
Bioorthogonal reactions are becoming a focal point in the development of bioconjugates, allowing for precise labeling and modification of biomolecules in living systems without interfering with native biochemical processes. - Theranostics:
The integration of therapeutic and diagnostic modalities (theranostics) is trending, with bioconjugates designed for simultaneous therapy and imaging, enhancing personalized medicine approaches. - Synthetic Biology Approaches:
Emerging research reflects the application of synthetic biology in developing novel bioconjugates, leveraging engineered proteins and peptides for therapeutic and diagnostic uses.
Declining or Waning
- Traditional Drug Delivery Systems:
There has been a noticeable reduction in studies focused solely on traditional drug delivery systems without the integration of novel bioconjugation techniques or nanotechnology. - Basic Bioconjugation Methodologies:
Research emphasizing basic bioconjugation techniques without novel applications or advancements is becoming less frequent, as the field increasingly demands innovative approaches and applications. - Non-specific Targeting Strategies:
Studies that do not incorporate targeted delivery mechanisms or specificity in bioconjugate design are seeing a decline, as the field moves towards more precise and effective targeting methodologies. - Classical Imaging Techniques:
There is a waning interest in classical imaging techniques that do not leverage the advancements in bioconjugation, as newer imaging modalities that integrate bioconjugates for enhanced specificity gain traction. - General Reviews without New Insights:
The publication of general reviews that do not provide new insights or advancements in the field is decreasing, as the journal aims to feature more cutting-edge research.
Similar Journals
JOURNAL OF MOLECULAR MODELING
Bridging Theory and Application in Molecular ResearchJOURNAL OF MOLECULAR MODELING, published by Springer, is a pivotal resource for researchers and professionals in the fields of chemistry, computer science, and molecular sciences. The journal's ISSN is 1610-2940, with an E-ISSN of 0948-5023, reflecting its commitment to disseminating cutting-edge research from 1996 to 2024. Although the journal does not operate under an Open Access model, it remains an invaluable platform for the publication of innovative studies related to computational methods, theoretical chemistry, and molecular simulations. With a notable categorization across multiple quartiles—including Q4 in Catalysis and Q3 in Computational Theory and Mathematics—the journal holds a distinct rank in Scopus, highlighting its influence and contribution to the discipline. The importance of this journal lies in its ability to bridge the gap between theoretical understanding and practical applications, making it essential reading for students and scholars seeking to advance their knowledge and research in molecular modeling.
RSC Chemical Biology
Advancing Interdisciplinary Discoveries in Life SciencesRSC Chemical Biology is a prestigious journal published by the Royal Society of Chemistry, providing a significant platform for researchers in the fields of biochemistry, genetics, and molecular biology. Launched in 2020, the journal aims to disseminate high-quality research that bridges the gap between chemistry and biology, promoting interdisciplinary studies and innovations that are essential for advancements in life sciences. With an emerging impact factor and ranking in the top quartile (Q1) for multiple categories such as Biochemistry and Molecular Biology, RSC Chemical Biology holds a prominent position in the academic landscape, evidenced by its Scopus rankings placing it in the top 20% and 30% of its respective fields. Although it does not operate under an open-access model, the journal's commitment to accessibility is reflected in its rigorous peer-review process and its role in shaping future scientific discourse. Research published in this journal is vital for contributing to our understanding of complex biological processes and fostering innovations that can lead to real-world applications.
ACS Bio & Med Chem Au
Pioneering interdisciplinary studies that shape the future of medicine.ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.
JOURNAL OF DRUG TARGETING
Transforming drug targeting with cutting-edge research.JOURNAL OF DRUG TARGETING, published by Taylor & Francis Ltd, is a premier academic journal dedicated to advancing the field of pharmaceutical sciences with a strong focus on drug delivery and targeting methodologies. With an impressive impact factor and recognized as a Q1 journal in the Pharmaceutical Science category, it ranks #23 out of 183 in Pharmacology, Toxicology and Pharmaceutics, placing it within the top 13% of journals in its field. The journal provides a platform for interdisciplinary research, showcasing innovative techniques and breakthrough findings that serve to improve therapeutic efficacy through precision targeting. Although it operates under a subscription model, researchers benefit from extensive access to pivotal studies spanning from 1986 to 2024. The JOURNAL OF DRUG TARGETING aims to foster collaboration among academics, professionals, and students, making it an essential resource for those seeking to leverage the latest advancements in drug development and delivery systems for improved healthcare outcomes.
Theranostics
Exploring the Intersection of Therapy and Diagnostics.Theranostics is a premier journal in the field of Medicine and Pharmacology, published by IVYSPRING INT PUBL. With its commitment to open access since 2011, it facilitates the widespread dissemination of innovative research, fostering collaboration and advancements in therapeutic diagnostics. The journal proudly holds a Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, Toxicology and Pharmaceutics, as of 2023, showcasing its esteemed position within the scientific community. Recognized globally, it ranks in the top 1%, with Scopus rankings placing it as 4th out of 398 in Medicine and 1st out of 43 in Pharmacology. Theranostics serves as a crucial platform for researchers, professionals, and students to explore cutting-edge developments as it converges multidisciplinary approaches to enhance patient care and treatment efficacy. With a focus on bridging experimental research and clinical applications, the journal is instrumental in shaping future therapies and diagnostic strategies.
BIOMACROMOLECULES
Fostering Innovation in Bioengineering DisciplinesBIOMACROMOLECULES, published by the American Chemical Society, stands as a premier journal in the fields of bioengineering, biomaterials, materials chemistry, and polymers and plastics. With a commendable impact factor that places it in the Q1 category across these disciplines, it is recognized for its influential research contributions and is ranked strongly within its scopes—16th in Polymers and Plastics and 26th in Biomaterials according to Scopus. Since its inception in 2000 and continuing through 2024, the journal has been pivotal in disseminating significant findings and technological advancements that propel the field forward. Although it does not currently have an open access option, the journal offers invaluable insights that are essential for researchers, professionals, and students engaged in the cutting-edge exploration of macromolecules and their diverse applications. With its address located at 1155 16th St, NW, Washington, DC 20036, BIOMACROMOLECULES is not just a repository of knowledge but also a vital platform for fostering collaboration and innovation within the scientific community.
MOLECULES
Empowering Researchers to Explore the Chemistry FrontierMOLECULES, published by MDPI, stands as a prominent open-access journal dedicated to the field of chemistry, with an exceptional reputation in various sub-disciplines. Since its inception in 1997, this journal has committed itself to the dissemination of innovative research, spanning topics in Analytical Chemistry, Organic Chemistry, Pharmaceutical Science, and Drug Discovery. With impressive rankings across Scopus categories—including a coveted Q1 designation in both Analytical Chemistry and Pharmaceutical Science—MOLECULES is recognized as a vital resource for researchers, professionals, and students aiming to stay at the forefront of scientific development. The journal’s data reflect its wide-ranging influence, holding high percentiles in multiple chemistry categories, thereby ensuring that its articles reach a significant audience. As an open-access journal, it provides unparalleled access to its content, available freely and globally, which promotes further advancement and collaboration within the scientific community. Its ongoing commitment to high-quality research from 1996 to 2024 reinforces its status as a leader in the academic publishing landscape.
Aggregate
Elevating scientific discourse across disciplines.Aggregate, published by WILEY, is a premier open-access journal established in 2020, dedicated to advancing the fields of Chemistry, Materials Chemistry, Materials Science, and Molecular Biology. Based in the United States, this rapidly rising journal (Q1 in various categories as of 2023) has quickly made its mark as a valuable resource, evidenced by its impressive Scopus rankings—ranking #6 in Chemistry (miscellaneous) and #13 in Materials Science (miscellaneous) among others—place it firmly in the top percentiles of these disciplines. With an emphasis on rigorous peer-reviewed research, Aggregate provides an essential platform for researchers to disseminate groundbreaking findings and innovative methodologies that propel the scientific community forward. As an open-access journal, it ensures that cutting-edge research is accessible to a global audience, thereby enriching the dialogue among professionals, researchers, and students alike. Explore the latest advancements and contribute to the vibrant discourse in these critical areas of science by publishing with Aggregate.
VIEW
Transforming Ideas into Innovations in Biomaterials Science.VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.
BIOINORGANIC CHEMISTRY AND APPLICATIONS
Transforming research into real-world applications.BIOINORGANIC CHEMISTRY AND APPLICATIONS, published by HINDAWI LTD, is a distinguished journal dedicated to advancing the field of bioinorganic chemistry, offering an open access platform since 2008. With an ISSN of 1565-3633 and E-ISSN of 1687-479X, this journal provides a global forum for researchers, practitioners, and scholars in the vibrant fields of Biochemistry, Inorganic Chemistry, and Organic Chemistry. Recognized for its scholarly impact, it holds an impressive Q2 rank in Biochemistry and Q1 ranks in both Inorganic and Organic Chemistry in the 2023 metrics. Catering to a diverse audience, the journal emphasizes the importance of interdisciplinary research and the application of inorganic chemistry in biological systems. With an accessible range of articles aimed at fostering scientific dialogue and innovation, BIOINORGANIC CHEMISTRY AND APPLICATIONS plays a crucial role in shaping future research and application in the chemical sciences.